Grant will help BioMotiv spinoff develop drugs to fight inflammation

Story excerpt provided by Crain’s Cleveland Business.

Written by Chuck Soder.

A $220,000 federal grant will help a BioMotiv spinoff company develop drugs designed to fight inflammation, according to a news release. The spinoff company, Sujana Biotech of Shaker Heights, is developing the technology with help from a San Diego-based biotechnology company called BioAtla.

Click here to read the complete article.

Originally published March 29, 2016.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: